Chernett Jorey has made headlines with his recent acquisition of 18,000 shares in Neuronetics, Inc., a company specializing in surgical and medical instruments. This transaction, reported on November 2, 2026, highlights Jorey's growing confidence in Neuronetics' potential for future growth.

The acquisition took place on October 30, 2026, at a price of $2.27 per share. Following this purchase, Jorey now owns a total of 10,620,988 shares in Neuronetics. This significant increase in ownership is noteworthy as it reflects Jorey's belief in the company's direction and prospects.

Background

Chernett Jorey is a significant shareholder in Neuronetics, Inc., which is listed under the Central Index Key (CIK) 0001227636. Neuronetics operates in the surgical and medical instruments and apparatus sector, specifically categorized under SIC 3841. The company is incorporated in Delaware and has its business address in Malvern, Pennsylvania. Recent filings indicate Jorey’s active involvement in the company, with multiple transactions reported in recent months.

What the Filing Says

According to the SEC filing (accession number 0000921895-26-002891), Jorey acquired 18,000 shares on October 30, 2026. The filing states, "transaction code P" indicating a purchase, and notes that Jorey now holds 10,620,988 shares following this transaction.

Impact

This acquisition may have implications for Neuronetics, as Jorey is now a ten percent owner of the company. His increased stake could signal to other investors a strong belief in the company's future, potentially influencing trading behaviors and investor sentiment within the surgical and medical instruments sector.

What's Next

The filing does not say what happens next. However, Jorey's continued involvement in Neuronetics may lead to further disclosures in the future as he navigates his role as a significant shareholder.